In this way, somatic mutations would increase the number of ECs that are null for endoglin (in HHT1) or null for ACVRL1 (in HHT2) and following exposure to angiogenic or inflammatory signals these “null” ECs would be associated with vascular malformations (Figure 3). Here, ACVRL1 is linked to vascular malformation.